Drug Safety
Risk of poor pregnancy outcomes in lupus patients continues to remain high, especially in the setting of high disease activity. Significant racial and ethnic disparities are also described in this…
11 months 2 weeks ago
An update on JAK inhibitors and cardiovascular risks
Dr. Antoni Chan ( @synovialjoints ) shares #EULAR23 developments on JAK/TYK2 inhibitors.
https://t.co/yZqHEg73bn https://t.co/CzVH62LEgL
11 months 2 weeks ago
Tune it at 1pm EST for RheumNow's daily #EULAR23 recaps. You can find us live on Twitter, YouTube and LinkedIn. https://t.co/t531csjXo8
11 months 2 weeks ago
✅Benefit of adding #HydroxyChloroquine #HCQ in refractory obstetric #APS
#EULAR2023 poster https://t.co/dgGY496dbh
11 months 2 weeks ago
Factors related to having a flare of arthritis during COVID-19 include female gender, higher disease activity, no DMARD at time of vaccination. Stopping DMARDs need to be weighed up against risk of flares, Pedro Machado, COVID-19 #EULAR2023 @RheumNow https://t.co/3sd32tF2kW
Podcasts
Don't You Know Who I Am (5.17.2024)-
My Cancelled Lecture (5.11.2024)
Roadblocks to reaching remission in lupus Sponsored by GSK US Medical Affairs
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1601919334745-0'); });
Poster Hall